bioAffinity Technologies, Inc. Proceeds from (Repayments of) Short-term Debt
bioAffinity Technologies, Inc. (BIAF) reported Proceeds from (Repayments of) Short-term Debt of -$45.38 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2026-03-16
- bioAffinity Technologies, Inc. proceeds from (repayments of) short-term debt for fiscal 2025 was -$45.38K, a 123.65% decline from fiscal 2024.
- bioAffinity Technologies, Inc. proceeds from (repayments of) short-term debt for fiscal 2024 was $191.85K.
- bioAffinity Technologies, Inc. proceeds from (repayments of) short-term debt for fiscal 2023 was -$251.75K, a 145.35% decline from fiscal 2022.
- bioAffinity Technologies, Inc. proceeds from (repayments of) short-term debt for fiscal 2022 was $555.15K.
| Period end | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|
| 2025-12-31 | -$45.38K 10-K · filed 2026-03-16 |
| 2024-12-31 | $191.85K 10-K · filed 2026-03-16 |
| 2023-12-31 | -$251.75K 10-K · filed 2024-04-01 |
| 2022-12-31 | $555.15K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |